Xubin Deng

1.2k total citations
27 papers, 948 citations indexed

About

Xubin Deng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xubin Deng has authored 27 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Xubin Deng's work include MicroRNA in disease regulation (14 papers), Circular RNAs in diseases (10 papers) and Cancer-related molecular mechanisms research (10 papers). Xubin Deng is often cited by papers focused on MicroRNA in disease regulation (14 papers), Circular RNAs in diseases (10 papers) and Cancer-related molecular mechanisms research (10 papers). Xubin Deng collaborates with scholars based in China, United States and United Kingdom. Xubin Deng's co-authors include Lei Ma, Gong Zhang, Kai‐Tai Yao, Minhua Wu, Siyi Li, Weiren Luo, Yanfen Ye, Bailu Peng, Weidong Li and Hai Gao and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Xubin Deng

27 papers receiving 944 citations

Peers

Xubin Deng

ONCOL

PRM

IMMUN

Federica Ganci Italy

Aibing Wu China

Jing-Hui Hou China

Yugang Wen China

Linda Fabris United States

Xianzi Wen China

Wenchang Lv China

Tong-Tao Yang China

Yat‐Yuen Lim Malaysia

Federica Ganci Italy

Xubin Deng

810 ×1.1

646 ×1.1

150 ×0.7

ONCOL

55 ×0.8

PRM

48 ×0.8

IMMUN

Citations per year, relative to Xubin Deng Xubin Deng (= 1×) peers Federica Ganci

Countries citing papers authored by Xubin Deng

Since Specialization

Citations

This map shows the geographic impact of Xubin Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xubin Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xubin Deng more than expected).

Fields of papers citing papers by Xubin Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xubin Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xubin Deng. The network helps show where Xubin Deng may publish in the future.

Co-authorship network of co-authors of Xubin Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Xubin Deng. A scholar is included among the top collaborators of Xubin Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xubin Deng. Xubin Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deng, Xubin, Qianbing Zhang, Fa Jin, et al.. (2024). Ailanthone disturbs cross-talk between cancer cells and tumor-associated macrophages via HIF1-α/LINC01956/FUS/β-catenin signaling pathway in glioblastoma. Cancer Cell International. 24(1). 397–397. 1 indexed citations

Zhang, Yue, Hao Wang, Ying Liu, et al.. (2022). Comprehensive analysis of DTYMK in pan-cancer and verification in lung adenocarcinoma. Bioscience Reports. 42(10). 6 indexed citations

Liang, Yingying, Xubin Deng, Lili Jiang, et al.. (2020). RASSF1A inhibits PDGFB-driven malignant phenotypes of nasopharyngeal carcinoma cells in a YAP1-dependent manner. Cell Death and Disease. 11(10). 855–855. 11 indexed citations

Deng, Xubin, et al.. (2020). Prognostic value of immune cell infiltration in bladder cancer: A gene expression‑based study. Oncology Letters. 20(2). 1677–1684. 8 indexed citations

Zhang, Gong, Ximin Chen, Lei Ma, et al.. (2020). LINC01419 facilitates hepatocellular carcinoma growth and metastasis through targeting EZH2-regulated RECK. Aging. 12(11). 11071–11084. 22 indexed citations

Lu, Yaoyong, et al.. (2019). MicroRNA‐224, negatively regulated by c‐jun, inhibits growth and epithelial‐to‐mesenchymal transition phenotype via targeting ADAM17 in oral squamous cell carcinoma. Journal of Cellular and Molecular Medicine. 23(8). 4913–4920. 12 indexed citations

Lu, Yaoyong, Yingying Liang, Xin Zheng, et al.. (2019). EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo−/radioresistance in nasopharyngeal carcinoma. Journal of Experimental & Clinical Cancer Research. 38(1). 82–82. 41 indexed citations

Chen, Yan, Xubin Deng, Weiquan Chen, et al.. (2019). Silencing of microRNA-708 promotes cell growth and epithelial-to-mesenchymal transition by activating the SPHK2/AKT/β-catenin pathway in glioma. Cell Death and Disease. 10(6). 448–448. 32 indexed citations

Liang, Yingying, et al.. (2018). RASSF6-mediated inhibition of Mcl-1 through JNK activation improves the anti-tumor effects of sorafenib in renal cell carcinoma. Cancer Letters. 432. 75–83. 13 indexed citations

10.

Gao, Hai, et al.. (2017). Down-regulation of microRNA-224 -inhibites growth and epithelial-to-mesenchymal transition phenotype -via modulating SUFU expression in bladder cancer cells. International Journal of Biological Macromolecules. 106. 234–240. 13 indexed citations

11.

Lyu, Xiaoming, et al.. (2017). miR-181a-5p, an inducer of Wnt-signaling, facilitates cell proliferation in acute lymphoblastic leukemia. Oncology Reports. 37(3). 1469–1476. 43 indexed citations

12.

Wu, Minhua, Xiaoxia Ye, Xubin Deng, et al.. (2016). Upregulation of metastasis-associated gene 2 promotes cell proliferation and invasion in nasopharyngeal carcinoma. OncoTargets and Therapy. 9. 1647–1647. 17 indexed citations

13.

Ma, Lei, Yongjian Zhou, Xiaojun Luo, et al.. (2016). Long non-coding RNA XIST promotes cell growth and invasion through regulating miR-497/MACC1 axis in gastric cancer. Oncotarget. 8(3). 4125–4135. 97 indexed citations

14.

Ma, Lei, Xubin Deng, Minhua Wu, Gong Zhang, & Jianqing Huang. (2014). Down‐regulation of miRNA‐204 by LMP‐1 enhances CDC42 activity and facilitates invasion of EBV‐associated nasopharyngeal carcinoma cells. FEBS Letters. 588(9). 1562–1570. 66 indexed citations

15.

Li, Weidong, et al.. (2014). The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E. Biochemical and Biophysical Research Communications. 449(2). 235–240. 33 indexed citations

16.

Zhang, Qianbing, Bing Xia, Yue Zhang, et al.. (2014). MTA1 Overexpression Induces Cisplatin Resistance Innasopharyngeal Carcinoma by Promoting Cancer Stem Cells Properties. Molecules and Cells. 37(9). 699–704. 19 indexed citations

17.

Li, Weidong, Xuejun Jin, Qianbing Zhang, et al.. (2014). Decreased expression of miR-204 is associated with poor prognosis in patients with breast cancer.. PubMed. 7(6). 3287–92. 67 indexed citations

18.

Luo, Weiren, Siyi Li, Bailu Peng, et al.. (2013). Embryonic Stem Cells Markers SOX2, OCT4 and Nanog Expression and Their Correlations with Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma. PLoS ONE. 8(2). e56324–e56324. 148 indexed citations

19.

Deng, Xubin, Lei Ma, Minhua Wu, et al.. (2013). miR-124 radiosensitizes human glioma cells by targeting CDK4. Journal of Neuro-Oncology. 114(3). 263–274. 83 indexed citations

20.

Deng, Xubin, Xiao Li, Fang Jin, Joseph R. Testa, & Guang‐Hui Xiao. (2011). Abstract A64: Adenovirus-mediated NK4 gene therapy for malignant mesothelioma.. Molecular Cancer Therapeutics. 10(11_Supplement). A64–A64. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact